National Heart Institute: Drug Shows Promise for Slowing Progression of Rare, Painful Genetic Disease
April 04, 2024
April 04, 2024
BETHESDA, Maryland, April 4 (TNSres) -- The National Institutes of Health's National Heart, Lung and Blood Institute issued the following media advisory:
* * *
NIH-supported clinical trial could lead to first effective treatment for ACDC disease
* * *
What: A drug used to treat certain bone diseases shows promise for slowing the progression of a rare, painful genetic condition that causes excessive calcium buildup in the arteries, known as arte . . .
* * *
NIH-supported clinical trial could lead to first effective treatment for ACDC disease
* * *
What: A drug used to treat certain bone diseases shows promise for slowing the progression of a rare, painful genetic condition that causes excessive calcium buildup in the arteries, known as arte . . .